Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.

Saved in:
Bibliographic Details
Title: Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.
Authors: Chen CD; Washington University in St. Louis, St. Louis, MO, USA., Franklin EE; Washington University in St. Louis, St. Louis, MO, USA., Li Y; Washington University in St. Louis, St. Louis, MO, USA., Joseph-Mathurin N; Washington University in St. Louis, St. Louis, MO, USA., Burns AL; Washington University in St. Louis, St. Louis, MO, USA., Hobbs DA; Washington University in St. Louis, St. Louis, MO, USA., McCullough AA; Washington University in St. Louis, St. Louis, MO, USA., Schultz SA; Massachusetts General Hospital, Boston, MA, USA., Xiong C; Washington University in St. Louis, St. Louis, MO, USA., Wang G; Washington University in St. Louis, St. Louis, MO, USA., Masellis M; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada., Hsiung GR; The University of British Columbia, Vancouver, BC, Canada., Gauthier S; McGill University, Montreal, QC, Canada., Berman SB; University of Pittsburgh, Pittsburgh, PA, USA., Roberson ED; University of Alabama at Birmingham, Birmingham, AL, USA., Honig LS; Taub Institute, Sergievsky Center, and Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA., Clarnette R; University of Western Australia, Crawley, WA, Australia., Ringman JM; Keck School of Medicine of USC, Los Angeles, CA, USA., Galvin JE; University of Miami Miller School of Medicine, Atlantis, FL, USA., Brooks W; Neuroscience Research Australia, Randwick, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia., Suzuki K; National Defense Medical College, Saitama, Japan., Black S; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; L.C. Campbell Cognitive Neurology Research Unit, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Neurology, University of Toronto, Toronto, ON, Canada.; Institute of Medical Science, University of Toronto, Toronto, ON, Canada., Levin J; Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.; German Center for Neurodegenerative Diseases (DZNE), 81377, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Aggarwal NT; Rush University Medical Center, Chicago, IL, USA., Jucker M; German Center for Neurodegenerative Diseases (DZNE), 72076, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany., Frosch MP; Massachusetts General Hospital, Boston, MA, USA., Kofler JK; University of Pittsburgh, Pittsburgh, PA, USA., White C 3rd; University of Texas Southwestern, Dallas, TX, USA., Keene CD; University of Washington, Seattle, WA, USA., Chen J; University of Nebraska Medical Center, Omaha, NE, USA., Daniels A; Washington University in St. Louis, St. Louis, MO, USA., Gordon BA; Washington University in St. Louis, St. Louis, MO, USA., Ibanez L; Washington University in St. Louis, St. Louis, MO, USA., Karch CM; Washington University in St. Louis, St. Louis, MO, USA., Llibre-Guerra J; Washington University in St. Louis, St. Louis, MO, USA., McDade E; Washington University in St. Louis, St. Louis, MO, USA., Morris JC; Washington University in St. Louis, St. Louis, MO, USA., Supnet-Bell C; Washington University in St. Louis, St. Louis, MO, USA., Allegri RF; Instituto de Investigaciones Neurológicas Fleni, Buenos Aires, Argentina., Lee JH; Korea University College of Medicine, Seoul, Korea., Day GS; Mayo Clinic, Jacksonville, FL, USA., Lopera F; University of Antioquia, Medellin, Colombia., Roh JH; Korea University College of Medicine, Seoul, Korea., Schofield PR; Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, NSW, Australia., Mills S; Washington University in St. Louis, St. Louis, MO, USA., Benzinger TLS; Washington University in St. Louis, St. Louis, MO, USA., Bateman RJ; Washington University in St. Louis, St. Louis, MO, USA., Perrin RJ; Washington University in St. Louis, St. Louis, MO, USA. rperrin@wustl.edu.
Corporate Authors: DIAN-TU Study Team, DIAN-Obs Study Team
Source: Acta neuropathologica [Acta Neuropathol] 2025 Jun 03; Vol. 149 (1), pp. 57. Date of Electronic Publication: 2025 Jun 03.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0533
DOI:10.1007/s00401-025-02890-7